Phase II placebo controlled study to evaluate the efficacy, safety and tolerability of RGH - 896 [radiprodil] in patients with pain due to diabetic sensor-motor peripheral neuropathy
Latest Information Update: 25 May 2006
At a glance
- Drugs Radiprodil (Primary)
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Therapeutic Use
- 25 May 2006 New trial record.